Get More Information on Diabetes Devices Market - Request Sample Report
The Diabetes Devices Market Size was valued at USD 30.26 Billion in 2023, and is expected to reach USD 57.15 Billion by 2032, and grow at a CAGR of 7.66%.
The diabetes products market is expanding significantly, driven by several key factors including the rising prevalence of diabetes, technological advancements, increased use of insulin-delivery devices, and escalating obesity rates. These factors are collectively shaping the market and influencing its growth trajectory. Diabetes is becoming a major global health concern. In 2023, it was reported that over 500 million people worldwide are living with diabetes, making it one of the top ten causes of death and disability. The prevalence of diabetes is projected to increase to 6.1% globally, with particularly high rates in North Africa, the Middle East, and Latin America. This rising prevalence underscores the urgent need for effective diabetes management solutions. Technological progress is a significant driver of market growth. Companies are focusing on developing and launching innovative diabetes management products. For example, in 2023, Insulet Corporation acquired Automated Glucose Control LLC, a company specializing in automated insulin delivery technology. This acquisition highlights the emphasis on enhancing diabetes management through advanced technology, which aims to improve patient outcomes and streamline diabetes care.
The adoption of insulin-delivery devices, including insulin pumps and continuous glucose monitors (CGMs), is growing. These devices provide precise control over insulin delivery and continuous monitoring of blood sugar levels, which are crucial for effective diabetes management. The increasing use of these devices reflects their importance in managing diabetes and reducing related complications. Rising obesity rates are contributing to the growing incidence of type 2 diabetes, as obesity is a major risk factor for the condition. The global increase in obesity amplifies the demand for diabetes products designed to manage and treat diabetes effectively. Diabetes devices enhance patient care by providing continuous monitoring and precise control over blood sugar levels, which helps reduce hospitalizations and mortality rates. Advanced technology in diabetes management is expected to influence future treatments and improve overall patient care. In summary, the diabetes products market is being driven by the high prevalence of diabetes, ongoing technological innovations, increasing use of insulin-delivery systems, and rising obesity rates, all contributing to enhanced patient care and better management of diabetes.
MARKET DYNAMICS:
Key Drivers:
The Sharp Increase in Diabetes in The Past Decade is Boosting the Growth of the Market.
Favorable National Health Strategies is Fueling the Growth of the Market.
Restraints:
Traditional Chinese Medicine as An Alternative is restraining the Growth of the Market.
The High Cost of Advanced Diabetes Management Devices is Hampering the Growth of the Market.
Opportunity:
Technological Innovations to Drive the Growth of Self-Monitoring Blood Glucose Monitoring Systems.
Increasing Collaborations, Partnerships, and Agreements Between Companies to Develop Integrated CGM Systems to Drive the Growth of this Market.
KEY MARKET SEGMENTATION:
By Type
In 2023, the insulin delivery devices segment generated the highest revenue and is projected to grow at a rate of 7.89% during the forecast period. The blood glucose monitoring devices segment is also expected to experience substantial growth during the forecast period due to the availability of affordable monitoring devices and their high level of accuracy in reading glucose levels. Companies are introducing cost-effective, technologically advanced, and user-friendly products through the use of emerging technologies and product launches. For instance, Dexcom plans to launch its new continuous glucose monitor, Stelo, in January 2024. This monitor is designed for individuals with Type 2 diabetes who do not require insulin. The FDA is currently reviewing the submission, which was made in the fourth quarter of 2023, and this is anticipated to drive the demand for blood glucose monitoring devices.
By End-Use
By end-use, the hospital segment dominated the market with a revenue share of 41% in 2023. Rising hospital admissions for diabetes patients are driving the sector, as those with diabetes are at three times higher risk of being ill than non-diabetic individuals. In the past few years, technology for diabetes has grown rapidly, with a strong emphasis on improving diabetes treatment in the medical sector. As a result, insulin pump usage has seen an explosive rise in hospitals and clinics. To illustrate, when the insulin is exposed to air and light for three days, patients must replace their insulin pumps with new ones, according to University Hospitals.
Meanwhile, with an approximated CAGR of 6.44% from 2023 to 2032, the diagnostic centers segment is expected to grow at the fastest speed during the projection period. In different healthcare settings, such as diagnostic centers, Glucose Monitoring Devices are being increasingly used. Patients with diabetes prefer to consult them at diagnostic centers to get results the same day and avoid long waiting times. In these diagnostic services, SMBG devices are widely used.
Need any customization research on Diabetes Devices Market - Enquiry Now
REGIONAL ANALYSIS:
The market in North America boasted a significant revenue share of 38.66% in 2023. The market is primarily driven by an increase in the number of older people, who are more likely to catch the disease, as well as the increase in diabetes afflicted by dietary changes leading to sedentary lifestyles, increased obesity prevalence, and the high cost of therapy. Many of the notable players, such as their operational headquarters in Abbott, Medtronic, Dexcom, and Insulet Corporation, are based in this area.
The US diabetes devices market is slated to register the highest CAGR in the forthcoming period. Abbott, Medtronic, Dexcom, and Insulet Corporation are some of the market players in the country. According to the Centers for Disease Control and Prevention report in November 2023, in the US, approximately 136 million adults are either currently diagnosed with diabetes or in a pre-diabetes state.
KEY PLAYERS:
The key market players are Medtronic plc, Abbott Laboratories, F.Hoffmann-La-Ltd., Bayer AG, Lifescan, Inc., B Braun Melsungen AG, Lifescan, Inc., Dexcom Inc., Insulet Corporation, Ypsomed Holdings, Companion Medical, Sanofi, Valeritas Holding Inc, Novo Nordisk, and others.
RECENT DEVELOPMENTS
Medtronic acquired EOFlow, a manufacturer of well-designed insulin devices, in May 2023. EOFlow has a fully functional web-based technology used for monitoring food consumption variations via smartphones. The incorporation of EOFlow’s product with Medtronic’s Meal Detection Technology algorithm and highly developed CGM is likely to increase the new company’s ability to cater to a wider range of consumers.
In April 2023, Undbio revealed that it is spending up to USD 100 million on the construction of a US-based insulin product plant. The South Korean corporation announced plans to set up a new production facility in West Virginia that would produce and market insulin across the US.
In July 2023, My Diabetes Tutor, a newly established enterprise aimed at improving the lives of people living with diabetes, received investments from CharmHealth and Bioverge.
|
Report Attributes |
Details |
|---|---|
|
Market Size in 2023 |
US$ 30.26 Billion |
|
Market Size by 2032 |
US$ 57.15 Billion |
|
CAGR |
CAGR of 7.66% From 2024 to 2032 |
|
Base Year |
2023 |
|
Forecast Period |
2024-2032 |
|
Historical Data |
2020-2022 |
|
Report Scope & Coverage |
Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
|
Key Segments |
•By Type (Blood Glucose Monitoring Devices, Continuous Glucose Monitoring Devices, Insulin Delivery Devices) |
|
Regional Analysis/Coverage |
North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
|
Company Profiles |
Medtronic plc, Abbott Laboratories, F.Hoffmann-La-Ltd., Bayer AG, Lifescan, Inc., B Braun Melsungen AG, Lifescan, Inc., Dexcom Inc., Insulet Corporation, Ypsomed Holdings, Companion Medical, Sanofi, Valeritas Holding Inc, Novo Nordisk and other players |
|
Key Drivers |
•The Sharp Increase in Diabetes in The Past Decade is Boosting the Growth of the Market. |
|
RESTRAINTS |
•Traditional Chinese Medicine as An Alternative is restraining the Growth of the Market. |
Ans: The Diabetes Devices Market is expected to grow at 7.66% CAGR from 2024 to 2032.
Ans: According to our analysis, the Diabetes Devices Market is anticipated to reach USD 57.15 billion By 2032.
Ans: The top players in the Diabetes Devices market are Abbott Laboratories, Dexcom, Inc., ACON Laboratories, Inc., Becton, Dickinson, and Company.
Ans: The Diabetes Devices Market study does not provide a value chain analysis.
Ans: Yes, you may request customization based on your company's needs before placing an purchase order.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume: Type and usage volumes of pharmaceuticals.
5.4 Healthcare Spending: Expenditure data by government, insurers, and out-of-pocket by patients
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Type Benchmarking
6.3.1 Type specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Type launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Diabetes Devices Market Segmentation, by Type
7.1 Chapter Overview
7.2 Blood Glucose Monitoring Devices
7.2.1 Blood Glucose Monitoring Devices Market Trends Analysis (2020-2032)
7.2.2 Blood Glucose Monitoring Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Continuous Glucose Monitoring Devices
7.3.1 Continuous Glucose Monitoring Devices Market Trends Analysis (2020-2032)
7.3.2 Continuous Glucose Monitoring Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Distribution Channel
7.4.1 Distribution Channel Market Trends Analysis (2020-2032)
7.4.2 Distribution Channel Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Diabetes Devices Market Segmentation, by Distribution Channel
8.1 Chapter Overview
8.2 Hospital Pharmacies
8.2.1 Hospital Pharmacies Market Trends Analysis (2020-2032)
8.2.2 Hospital Pharmacies Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Retail Pharmacies
8.3.1 Retail Pharmacies Market Trends Analysis (2020-2032)
8.3.2 Retail Pharmacies Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Diabetes Clinics/Centers
8.4.1 Diabetes Clinics/Centers Market Trends Analysis (2020-2032)
8.4.2 Diabetes Clinics/Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Online Pharmacies
8.5.1 Online Pharmacies Market Trends Analysis (2020-2032)
8.5.2 Online Pharmacies Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 Others
8.6.1 Others Market Trends Analysis (2020-2032)
8.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Diabetes Devices Market Segmentation, by End-Use
9.1 Chapter Overview
9.2 Hospitals
9.2.1 Hospitals Market Trends Analysis (2020-2032)
9.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Homecare
9.3.1 Homecare Market Trends Analysis (2020-2032)
9.3.2 Homecare Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Diagnostic Centers
9.4.1 Diagnostic Centers Market Trends Analysis (2020-2032)
9.4.2 Diagnostic Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Diabetes Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.4 North America Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.2.5 North America Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.6.2 USA Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.2.6.3 USA Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.7.2 Canada Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.2.7.3 Canada Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.8.2 Mexico Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.2.8.3 Mexico Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Diabetes Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.6.2 Poland Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.6.3 Poland Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.7.2 Romania Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.7.3 Romania Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Diabetes Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.4 Western Europe Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.5 Western Europe Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.6.2 Germany Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.6.3 Germany Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.7.2 France Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.7.3 France Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.8.2 UK Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.8.3 UK Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.9.2 Italy Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.9.3 Italy Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.10.2 Spain Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.10.3 Spain Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.13.2 Austria Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.13.3 Austria Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Diabetes Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.4 Asia Pacific Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.5 Asia Pacific Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.6.2 China Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.6.3 China Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.7.2 India Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.7.3 India Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.8.2 Japan Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.8.3 Japan Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.9.2 South Korea Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.9.3 South Korea Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.10.2 Vietnam Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.10.3 Vietnam Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.11.2 Singapore Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.11.3 Singapore Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.12.2 Australia Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.12.3 Australia Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Diabetes Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.4 Middle East Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.5 Middle East Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.6.2 UAE Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.6.3 UAE Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Diabetes Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.4 Africa Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.2.5 Africa Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Diabetes Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.4 Latin America Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.5 Latin America Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.6.2 Brazil Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.6.3 Brazil Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.7.2 Argentina Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.7.3 Argentina Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.8.2 Colombia Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.8.3 Colombia Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Diabetes Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Diabetes Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Diabetes Devices Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
11. Company Profiles
11.1 Medtronic plc
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Types/ Services Offered
11.1.4 SWOT Analysis
11.2 Abbott Laboratories
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Types/ Services Offered
11.2.4 SWOT Analysis
11.3 F.Hoffmann-La-Ltd.
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Types/ Services Offered
11.3.4 SWOT Analysis
11.4 Bayer AG
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Types/ Services Offered
11.4.4 SWOT Analysis
11.5 Lifescan, Inc.
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Types/ Services Offered
11.5.4 SWOT Analysis
11.6 B Braun Melsungen AG
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Types/ Services Offered
11.6.4 SWOT Analysis
11.7 Lifescan, Inc.
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Types/ Services Offered
11.7.4 SWOT Analysis
11.8 Dexcom Inc.
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Types/ Services Offered
11.8.4 SWOT Analysis
11.9 Insulet Corporation
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Types/ Services Offered
11.9.4 SWOT Analysis
11.10 Ypsomed Holdings
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Types/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Type
Blood Glucose Monitoring Devices
Continuous Glucose Monitoring Devices
Insulin Delivery Devices
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Diabetes Clinics/Centers
Online Pharmacies
Others
By End-use
Hospitals
Homecare
Diagnostic Centers
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Advanced Visualization Market was valued at USD 3.64 Billion in 2023 and it is projected to reach USD 9.77 Billion by 2032, registering a compound annual growth rate (CAGR) of 11.6% from 2024 to 2032.
The Pharmaceutical Sterility Testing Market Size was valued at USD 1.50 billion in 2023 and is expected to reach USD 3.84 billion by 2032 and grow at a CAGR of 11.03% over the forecast period 2024-2032.
The Surgical Robots Market Size was valued at USD 3.95 billion in 2023, and is expected to reach USD 8.79 billion by 2032, and grow at a CAGR of 9.3% over the forecast period 2024-2032.
The Point of Care Lipid Test Market size was estimated USD 305.53 million in 2023 and is expected to reach USD 444.36 million by 2032 at a CAGR of 4.25% during the forecast period of 2024-2032.
The Healthcare Provider Network Management Market Size was valued at $4.23 Bn in 2023 & will reach $13.02 Bn by 2031 & grow at a CAGR of 15% by 2024-2031.
The Glioblastoma Multiforme Treatment Market size was valued at USD 2.69 billion in 2023 and is expected to reach at USD 5.68 billion by 2031 and grow at a CAGR of 9.8% over the forecast period of 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
